Literature DB >> 14762714

Nitric oxide generation and poly(ADP ribose) polymerase activation precede beta-cell death in rats with a single high-dose injection of streptozotocin.

Ryuichi Wada1, Soroku Yagihashi.   

Abstract

Streptozotocin (STZ) is widely used for the induction of diabetes in animals by causing destruction of pancreatic beta cells. This experiment was designed to elucidate the sequential process of beta-cell destruction in rats with a single high-dose injection of STZ. At 0, 2, 5, 8 and 24 h after injection, rats were perfused with Krebs-Ringer buffer with dichlorofluorescein diacetate (DCF-DA), a marker for free radicals, and the pancreata were pathologically analyzed. Injection of STZ rapidly elicited an increase in fluorescence of DCF-DA in beta cells at 2 h after the injection. The fluorescence was diminished by carboxy-PTIO, a specific scavenger of nitric oxide (NO), but not by L-NAME, an inhibitor of NO synthase. During this process, an inducible form of NO synthase was not detected. Thereafter, upregulated expression of poly(ADP ribose) polymerase (PARP) and massive beta-cell death were detected at 5-8 h after injection. Migration of macrophages into the islet was conspicuous at 24 h, clearing up the debris of destroyed beta cells. Nicotinamide, a PARP inhibitor, significantly inhibited beta-cell death without apparent suppression of NO generation at 2 h. The current study documented serial processes of STZ-induced beta-cell death, starting with NO generation and PARP activation followed by a clearance with macrophages, where the activation of PARP plays a central role in beta-cell death.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14762714     DOI: 10.1007/s00428-003-0967-z

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  25 in total

1.  Studies of the diabetogenic action of streptozotocin.

Authors:  A Junod; A E Lambert; L Orci; R Pictet; A E Gonet; A E Renold
Journal:  Proc Soc Exp Biol Med       Date:  1967-10

2.  The inhibitory potency and selectivity of arginine substrate site nitric-oxide synthase inhibitors is solely determined by their affinity toward the different isoenzymes.

Authors:  R Boer; W R Ulrich; T Klein; B Mirau; S Haas; I Baur
Journal:  Mol Pharmacol       Date:  2000-11       Impact factor: 4.436

3.  Effect of poly(ADP-ribose) synthetase inhibitor administration to rats before and after injection of alloxan and streptozotocin on islet proinsulin synthesis.

Authors:  Y Uchigata; H Yamamoto; H Nagai; H Okamoto
Journal:  Diabetes       Date:  1983-04       Impact factor: 9.461

Review 4.  A proposal of three distinct subtypes of type 1 diabetes mellitus based on clinical and pathological evidence.

Authors:  A Imagawa; T Hanafusa; J Miyagawa; Y Matsuzawa
Journal:  Ann Med       Date:  2000-11       Impact factor: 4.709

5.  Nitric oxide generation from streptozotocin.

Authors:  N S Kwon; S H Lee; C S Choi; T Kho; H S Lee
Journal:  FASEB J       Date:  1994-05       Impact factor: 5.191

6.  Nitric oxide generation during cellular metabolization of the diabetogenic N-methyl-N-nitroso-urea streptozotozin contributes to islet cell DNA damage.

Authors:  K D Kröncke; K Fehsel; A Sommer; M L Rodriguez; V Kolb-Bachofen
Journal:  Biol Chem Hoppe Seyler       Date:  1995-03

7.  Apoptotic cell death triggered by nitric oxide in pancreatic beta-cells.

Authors:  H Kaneto; J Fujii; H G Seo; K Suzuki; T Matsuoka; M Nakamura; H Tatsumi; Y Yamasaki; T Kamada; N Taniguchi
Journal:  Diabetes       Date:  1995-07       Impact factor: 9.461

8.  Streptozotocin diabetes. Correlation with extent of depression of pancreatic islet nicotinamide adenine dinucleotide.

Authors:  T Anderson; P S Schein; M G McMenamin; D A Cooney
Journal:  J Clin Invest       Date:  1974-09       Impact factor: 14.808

9.  Early midzonal oxidative stress preceding cell death in hypoperfused rat liver.

Authors:  M Suematsu; H Suzuki; H Ishii; S Kato; T Yanagisawa; H Asako; M Suzuki; M Tsuchiya
Journal:  Gastroenterology       Date:  1992-09       Impact factor: 22.682

10.  Biochemical evidence for nitric oxide formation from streptozotocin in isolated pancreatic islets.

Authors:  J Turk; J A Corbett; S Ramanadham; A Bohrer; M L McDaniel
Journal:  Biochem Biophys Res Commun       Date:  1993-12-30       Impact factor: 3.575

View more
  5 in total

Review 1.  Peripheral Neuropathy in Mouse Models of Diabetes.

Authors:  Corinne G Jolivalt; Katie E Frizzi; Lucie Guernsey; Alex Marquez; Joseline Ochoa; Maria Rodriguez; Nigel A Calcutt
Journal:  Curr Protoc Mouse Biol       Date:  2016-09-01

2.  Alpha1-antitrypsin monotherapy prolongs islet allograft survival in mice.

Authors:  Eli C Lewis; Leland Shapiro; Owen J Bowers; Charles A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-10       Impact factor: 11.205

3.  Rat brain glucose transporter-2, insulin receptor and glial expression are acute targets of intracerebroventricular streptozotocin: risk factors for sporadic Alzheimer's disease?

Authors:  A Knezovic; A Loncar; J Homolak; U Smailovic; J Osmanovic Barilar; L Ganoci; N Bozina; P Riederer; Melita Salkovic-Petrisic
Journal:  J Neural Transm (Vienna)       Date:  2017-05-03       Impact factor: 3.575

4.  D-Xylose as a sugar complement regulates blood glucose levels by suppressing phosphoenolpyruvate carboxylase (PEPCK) in streptozotocin-nicotinamide-induced diabetic rats and by enhancing glucose uptake in vitro.

Authors:  Eunju Kim; Yoo-Sun Kim; Kyung-Mi Kim; Sangwon Jung; Sang-Ho Yoo; Yuri Kim
Journal:  Nutr Res Pract       Date:  2015-06-19       Impact factor: 1.926

5.  Pathogenesis of Type 1 Diabetes Mellitus and Rodent Experimental Models.

Authors:  I G Gvazava; O S Rogovaya; M A Borisov; E A Vorotelyak; A V Vasiliev
Journal:  Acta Naturae       Date:  2018 Jan-Mar       Impact factor: 1.845

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.